Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Affymax Company Description
Affymax, Inc. does not have significant operations.
Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States.
The company was founded in 2001 and is based in New York, New York.
Affymax, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Jonathan Couchman |
Contact Details
Address: 630 Fifth Avenue New York, Delaware 10020 United States | |
| Phone | 650 812 8700 |
Stock Details
| Ticker Symbol | AFFY |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US00826A1097 |
| SIC Code | 9995 |
Key Executives
| Name | Position |
|---|---|
| Jonathan M. Couchman CFA | Chief Executive Officer, President and Director |
| Mark G. Thompson | Chief Financial Officer and Secretary |
| Dr. Tracy J. Dunn Ph.D., J.D. | Vice President of Intellectual Property and Legal Affairs |